Clinical Research (EMAS)

EMAS Pharma provides specialist drug development services that maximize speed to market and optimize commercialization post-approval, right to the end of product life-cycle. This is all with the purpose of discovering improved methods of treating patients.

What we do

  • Clinical operations :– pharmaceuticals, biotech products, medical devices: early phase clinical development (I and IIa), phase IIb and III, late phase clinical trials – phase IIIb and IV, clinical research associates and project management staff, advice on study design and strategy, medical writing and submissions, medical monitoring
  • Drug safety :- clinical and post-marketing pharmacovigilance, case processing, data entry and regulatory reporting, development of PV Standard Operating Procedures
  • Strategic consultancy
  • Regulatory affairs :- global regulatory support throughout product lifecycle, strategic and scientific advice, legal counsel
  • Medical affairs :- Promotional copy review and approval, disclosure of payments to healthcare professionals, medical information services

Why we do it?

A key measure of the success of our services is the shortening of drug development time, which means that patients receive innovative medicines as early as possible. Our clients benefit commercially by taking advantage of maximum patent life and a comprehensive clinical evidence base to support product marketing.

How we do it

We bring decades of experience and offer insight from the perspective of big and small pharma, biotech, medical device and regulatory authority perspectives. Our track record demonstrates consistent success in implementing clinical research, medical affairs, pharmacovigilance and regulatory affairs worldwide.

We aim to build long term, mutually beneficial partnerships with our clients. We practice the following values in delivering our service:

  • Take ownership of work
  • Accountable for maintaining high standards
  • Act fairly with all parties – clients, suppliers and internal staff
  • Ethical behavior
  • Flexible, trusting and caring
  • Encourage innovation and creativity
  • Teamwork
  • Focus on the fact we ultimately deal with the lives of patients

 

View the full EMAS Website

Do you have a question about this service?

Dr. Peter Kennerley

Chief Executive Officer, EMAS Pharma

+44 (0)1462 424400